Corrigendum to "Magnetic Resonance Imaging and targeted biopsies compared to transperineal mapping biopsies prior to salvage focal therapy/ablation in localised and metastatic recurrent prostate cancer after radiotherapy. Primary Outcomes from the FORECAST Trial" [Eur Urol 2022;81(6):598-605]
Eur Urol. 2023 Apr;83(4):e117-e118.
doi: 10.1016/j.eururo.2023.01.004.
Epub 2023 Jan 19.
1 Imperial Prostate, Division of Surgery, Department of Surgery and Cancer, Imperial College London, London, UK; Imperial Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK; Division of Surgery and Interventional Sciences, University College London, London, UK. Electronic address: [email protected].
2 Division of Surgery and Interventional Sciences, University College London, London, UK.
3 Department of Statistical Science, University College London, London, UK.
4 Division of Medicine, Faculty of Medicine, University College London, London, UK; Department of Oncology, King's College London, London, UK; Department of Oncology, Maidstone and Tunbridge Wells Hospital, Maidstone, UK; School of Cancer & Pharmaceutical Sciences, King's College London, Queen Square, London WC1N 3BG, UK; High Dimensional Neurology, Department of Brain Repair and Rehabilitation, UCL Queen Square Institute of Neurology, University College London, London, UK.
5 Division of Surgery and Interventional Sciences, University College London, London, UK; Department of Radiology, University College London Hospital NHS Foundation Trust, London, UK.
6 Division of Medicine, Faculty of Medicine, University College London, London, UK.
7 Department of Urology, Basingstoke and North Hampshire Hospital, Hampshire Hospitals NHS Foundation Trust, Basingstoke, UK; Urology Department, Ain Shams University Hospitals, Cairo, Egypt.
8 Department of Nuclear Medicine, St. Bartholomew's Hospital, Barts Health NHS Trust, London, UK; Institute of Nuclear Medicine, University College London Hospitals NHS Foundation Trust, London, UK.
9 Division of Medicine, Faculty of Medicine, University College London, London, UK; Department of Radiology, Royal Marsden NHS Foundation Trust, London, UK.
10 Division of Medicine, Faculty of Medicine, University College London, London, UK; Department of Radiology, University College London Hospital NHS Foundation Trust, London, UK.
11 Department of Histopathology, University College London Hospital NHS Foundation Trust, London, UK.
12 Division of Surgery and Interventional Sciences, University College London, London, UK; Department of Urology, University College London Hospital NHS Foundation Trust, London, UK.
13 Sussex Cancer Centre. Royal Sussex County Hospital, Brighton, UK.
14 Department of Urology, University Hospital Southampton NHS Trust, Southampton, UK.
15 Department of Urology, Basingstoke and North Hampshire Hospital, Hampshire Hospitals NHS Foundation Trust, Basingstoke, UK.
16 Department of Urology, The Princess Alexandra Hospital NHS Trust, Harlow, UK.
18 Department of Oncology, University College London and University College London Hospital NHS Foundation Trust, London, UK.
19 Institute of Nuclear Medicine, University College London Hospitals NHS Foundation Trust, London, UK.
20 Imperial Prostate, Division of Surgery, Department of Surgery and Cancer, Imperial College London, London, UK; Imperial Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK.
21 Department of Oncology, Queen Elizabeth Hospital, Kings Lynn, UK.